Article
Opioid receptor A118G polymorphism does not affect the consumption of sufentanil and ropivacaine by patient-controlled epidural analgesia after cesarean section.
Therapeutic drug monitoring - 1 Feb 2015
Xu Guang-Hong, Gao Min, Sheng Qi-Ying, Liu Xue-Sheng, Gu Er-Wei
Abstract excerpt
BACKGROUND: Previous reports have suggested that polymorphism of the opioid receptor A118G affects the efficacy of opioid analgesia. The aim of this study was to investigate whether such polymorphism contributed to variability in epidural mixture (sufentanil plus ropivacaine) requirements through patient-controlled epidural analgesia (PCEA) after cesarean section. METHODS: One hundred eighty consenting women...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
